ArticleOncoTargets and therapy2017

Intensity-modulated radiotherapy plus nimotuzumab with or without concurrent chemotherapy for patients with locally advanced nasopharyngeal carcinoma.

Jianfeng Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.